Heartburn pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 10: Line 10:
The [[gastric acid]] and the [[pepsin]] damages the epithelium and causes an inflammatory response mediated by [[IL-8]] and [[IL-1B]]. These [[cytokines]] stimulate inflammation and sensitizes the [[peripheral nerves]] in the [[mucosa]] which mediates the [[pain]]. It is believed that the release of such [[cytokines]] is mediated by an increased production of [[PGE2]] and [[ATP]] by the [[epithelium]].
The [[gastric acid]] and the [[pepsin]] damages the epithelium and causes an inflammatory response mediated by [[IL-8]] and [[IL-1B]]. These [[cytokines]] stimulate inflammation and sensitizes the [[peripheral nerves]] in the [[mucosa]] which mediates the [[pain]]. It is believed that the release of such [[cytokines]] is mediated by an increased production of [[PGE2]] and [[ATP]] by the [[epithelium]].
With the most recent research findings, it is believed that the [[gastric acid]] does not directly cause [[heartburn]], but causes it using a myriad of [[inflammatory]] mechanisms which are being elucidated and may be targets of new [[therapeutic]] drugs in the future.<ref name="pmid27206157">{{cite journal| author=Miwa H, Kondo T, Oshima T| title=Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment. | journal=Curr Opin Gastroenterol | year= 2016 | volume= 32 | issue= 4 | pages= 344-52 | pmid=27206157 | doi=10.1097/MOG.0000000000000282 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27206157  }} </ref>
With the most recent research findings, it is believed that the [[gastric acid]] does not directly cause [[heartburn]], but causes it using a myriad of [[inflammatory]] mechanisms which are being elucidated and may be targets of new [[therapeutic]] drugs in the future.<ref name="pmid27206157">{{cite journal| author=Miwa H, Kondo T, Oshima T| title=Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment. | journal=Curr Opin Gastroenterol | year= 2016 | volume= 32 | issue= 4 | pages= 344-52 | pmid=27206157 | doi=10.1097/MOG.0000000000000282 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27206157  }} </ref>
==Pathology==
The [[esophagus]] is lined by [[nonkeratinizing]], [[stratified squamous epithelium]], and the [[stomach]] by [[columnar epithelium]] - in which every cell has a small surface area in contact with the organ lumen.
The [[squamocolumnar junction]] is the point, where the [[epithelium]] lining the [[esophagus]] meets the [[epithelium]] lining the [[gastric mucosal folds]]. The [[gastroesophageal junction]] is the anatomic place where the [[esophagus]] meets the [[stomach]] and it is located at the same place as the [[squamocolumnar junction]]. Patients with [[gastroesophageal reflux disease]] have a [[squamocolumnar junction]] which is moved proximally due to the changes occurring at the esophageal [[epithelium]], which gradually changes into [[columnar epithelium]], looking similarly as the [[gastric epithelium]], and being located above the anatomical junction.
Many changes have been reported in the esophageal epithelium in patients with [[gastroesophageal reflux disease]], as a response to damage. These changes have been summarized in the Esohisto project:


==References==
==References==

Revision as of 16:41, 1 September 2020

Heartburn Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Heartburn from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT-Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Heartburn pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Heartburn pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onHeartburn pathophysiology

CDC on Heartburn pathophysiology

Heartburn pathophysiology in the news

Blogs on Heartburn pathophysiology

Directions to Hospitals Treating Heartburn

Risk calculators and risk factors for Heartburn pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: José Eduardo Riceto Loyola Junior, M.D.[2]

Overview

The sensation of heartburn is caused by exposure of the lower esophagus to the acidic contents of the stomach. Normally, the lower esophageal sphincter (LES) separating the stomach from the esophagus is supposed to contract to prevent this situation. If the sphincter relaxes for any reason (as normally occurs during swallowing), stomach contents, mixed with gastric acid, can return into the esophagus. This return is also known as reflux, and may progress to gastroesophageal reflux disease (GERD) if it occurs frequently. If this is the case, the gastric acid and pepsin now located in the esophagus can injure the tight junction proteins in the esophageal epithelium. This results in increased paracellular permeability and dilated intercellular space and edema in the submucosa, which is amplified by an immunological mechanism mediated by inflammatory cytokines.[1]

Pathophysiology

Heartburn is the burning pain caused by the reflux of gastric acid and pepsin from the stomach into the esophagus. These substances enter the esophagus due to a dysfunctional lower esophagus sphincter, which in normal conditions should now allow the occurrence of such reflux. This can happen due to many causes such as hiatal hernia, use of medications which causes relaxation of the lower esophagus sphincter or due to abnormal relaxation or weakening of the lower esophagus sphincter which causes the gastroesophageal reflux disease. The gastric acid and the pepsin damages the epithelium and causes an inflammatory response mediated by IL-8 and IL-1B. These cytokines stimulate inflammation and sensitizes the peripheral nerves in the mucosa which mediates the pain. It is believed that the release of such cytokines is mediated by an increased production of PGE2 and ATP by the epithelium. With the most recent research findings, it is believed that the gastric acid does not directly cause heartburn, but causes it using a myriad of inflammatory mechanisms which are being elucidated and may be targets of new therapeutic drugs in the future.[1]

Pathology

The esophagus is lined by nonkeratinizing, stratified squamous epithelium, and the stomach by columnar epithelium - in which every cell has a small surface area in contact with the organ lumen. The squamocolumnar junction is the point, where the epithelium lining the esophagus meets the epithelium lining the gastric mucosal folds. The gastroesophageal junction is the anatomic place where the esophagus meets the stomach and it is located at the same place as the squamocolumnar junction. Patients with gastroesophageal reflux disease have a squamocolumnar junction which is moved proximally due to the changes occurring at the esophageal epithelium, which gradually changes into columnar epithelium, looking similarly as the gastric epithelium, and being located above the anatomical junction.

Many changes have been reported in the esophageal epithelium in patients with gastroesophageal reflux disease, as a response to damage. These changes have been summarized in the Esohisto project:

References

  1. 1.0 1.1 Miwa H, Kondo T, Oshima T (2016). "Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment". Curr Opin Gastroenterol. 32 (4): 344–52. doi:10.1097/MOG.0000000000000282. PMID 27206157.